Navigation Links
Codexis Signs First Japanese Biocatalysis Collaboration With Dainippon Sumitomo Pharma
Date:1/25/2011

REDWOOD CITY, Calif., Jan. 25, 2011 /PRNewswire/ -- Codexis, Inc. (Nasdaq: CDXS) today announced the company's first biocatalysis collaboration in Japan, with Dainippon Sumitomo Pharma Co., Ltd. (DSP), one of the ten largest Japanese pharmaceutical manufacturers.

Under the agreement, Codexis will supply biocatalysis screening products and services to DSP for use in selected undisclosed therapeutic products in its development pipeline.  Codexis technology is used by innovator pharmaceutical companies worldwide to reduce cost, increase manufacturing efficiency and reduce environmental impact.  

"We are very pleased to be entering the Japanese market through this important collaboration with DSP," said Joseph Sarret, M.D., President, Codexis Pharmaceutical Services and Enzyme Products.  "DSP has identified Codexis technology as a key component in its drive to develop green, sustainable manufacturing processes to serve their key markets, and we look forward to a productive partnership."

Codexis is a clean technology company. Codexis develops optimized biocatalysts that make industrial processes faster, cleaner and more efficient. Codexis' technology is commercialized with leading global pharmaceutical companies and in development for advanced biofuels with Shell. Other potential markets include carbon capture, water treatment and chemicals. For more information, see www.codexis.com.  

Dainippon Sumitomo Pharma Co., Ltd. is a multibillion dollar, top ten listed pharmaceutical company in Japan with a diverse portfolio of pharmaceutical, animal health and food and specialty products. DSP aims to produce innovative pharmaceutical products in the CNS field, which has been designated as the key therapeutic area, and the specialty area, designated as a frontier therapeutic area. DSP has more than 7,000 employees worldwide. Additional information about DSP is available through its corporate website at www.ds-pharma.com.

Codexis Forward-Looking Statements

This press release contains forward-looking statements relating to Codexis' collaboration with Dainippon Sumitomo Pharma. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond our control and that could materially affect actual results. Factors that could materially affect actual results can be found in Codexis Quarterly Report on Form 10-Q dated November 4, 2010 including under the caption "Risk Factors." Codexis expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law.

Contacts: 

Media: Lyn Christenson, lyn.christenson@codexis.com, 650-421-8144 or Saskia Sidenfaden, ssidenfaden@mww.com, 212-827-3771. Investors:  Robert Lawson, robert.lawson@codexis.com, 650-421-8137.


'/>"/>
SOURCE Codexis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Codexis to Announce Fourth Quarter 2010 Financial Results on February 3, 2011
2. Codexis to Present at Piper Conference
3. Codexis to Announce Third Quarter 2010 Financial Results October 28, 2010
4. Codexis Expands Codex® Panel Product Family at CPhI
5. Codexis to Present at the Pacific Crest Technology Leadership Forum
6. Codexis Names Peter Strumph SVP, Commercial Operations
7. Codexis CEO Alan Shaw Named Ernst & Young Entrepreneur Of The Year® 2010 Recipient in Northern California
8. Codexis, Inc. Announces Pricing of Initial Public Offering
9. Codexis Expands Pharmaceutical Manufacturing Partnerships
10. Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering
11. Codexis Expands Collaboration with Teva
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... -- The global peripheral I.V. catheter market accounted for ... to grow at a CAGR of 6.0% during 2016-2022. ... share in the global market between the two types ... hospital segment accounted for the highest share in the ... I.V. catheter market is witnessing high growth rate, due ...
(Date:1/23/2017)... Endo International plc (NASDAQ / TSX: ENDP) and the ... motion in the U.S. District Court for the Northern ... entry of a ten-year Stipulated Order for Permanent Injunction.  ... and Endo relating to the patent infringement settlements Endo ... Lidoderm® products.  It also resolves the FTC,s claims against ...
(Date:1/23/2017)... MouthWatch LLC announced today that its flagship product, ... best intraoral camera on DentalCompare,s list of Top Dental ... #1 product was the CollaPlug Absorbable Collagen Wound Dressing ... "…incredibly popular because it is by far the most economical ... price, it doesn,t sacrifice quality imaging." ...
Breaking Medicine Technology:
(Date:1/24/2017)... ... January 23, 2017 , ... Texas Home Health, an ... two personal care service companies: Padre Home Health in Corpus Christi, Texas, and ... , Well regarded in their respective markets, these two agencies align with Texas ...
(Date:1/24/2017)... Clara, CA (PRWEB) , ... January 23, 2017 ... ... announces the launch of a new plugin that allows sleep centers to automatically ... Sleep Device Interface (SDI)—is a thin client browser plugin is quickly installed on ...
(Date:1/23/2017)... ... January 23, 2017 , ... PKF O’Connor Davies ... J. Nelson, a senior accountant at the Firm, will participate in the 40th Annual ... Over 200 runners will race up 1,576 steps, a vertical distance equal to about ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... ... the highly acclaimed series, Innovations with Ed Begley, Jr., scheduled to broadcast Saturday, ... technology behind SmartCap, which was founded in 2008 to address the limitations of ...
(Date:1/23/2017)... ... January 23, 2017 , ... The Masters ... management and evaluation leaders with decades of experience who remain current practitioners in ... States healthcare system, there is a renewed demand for versatile, data-driven leadership.The American ...
Breaking Medicine News(10 mins):